TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
AGEN

Agenus Inc

Healthcare · Biotechnology

8.50$ +0.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement AGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +255.7% -9.0% +89.9% -14.2% +307.9% -41.2% +235.3% -66.8% +59.5% -33.8% +10.4%
– +215.2% +34.8% +22.3% +7.3% +35.1% -13.9% +25.6% +8.3% +20.5% -34.4% -48.5%
– – – – – – – – -187.4% – – –
– +215.2% +34.8% +22.3% +7.3% +35.1% -15.3% +25.2% -90.5% +1,281.8% -33.7% -49.0%
– +33.5% +16.8% +1.9% +10.7% +23.3% +28.6% +28.9% +6.1% -2.8% -8.7% -24.3%
– +33.5% +16.8% +1.9% +10.7% +38.8% +16.6% +45.3% -8.7% -2.5% -13.1% -19.9%
– – – – – – – – -796.9% – – –
– +423.1% +162.4% +9.0% +33.9% +64.0% +47.3% +7.6% -5.9% +58.3% +20.1% -53.0%
– – – – – – – – – – – –
– -205.3% – – – – +52.3% +15.2% -38.1% -128.6% – –
– – – – – – – – – – – –
– – – – – – – – -469.7% – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?